19-35631365-C-G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024321.5(RBM42):c.402C>G(p.Asp134Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,614,134 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024321.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152242Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000557 AC: 14AN: 251484 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000520 AC: 76AN: 1461892Hom.: 0 Cov.: 32 AF XY: 0.0000495 AC XY: 36AN XY: 727246 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74380 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.402C>G (p.D134E) alteration is located in exon 4 (coding exon 4) of the RBM42 gene. This alteration results from a C to G substitution at nucleotide position 402, causing the aspartic acid (D) at amino acid position 134 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at